3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
2
Neoplasms
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Liver Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Anxiety Disorders
1
Interventions
Blood Specimen Collection
38
pembrolizumab
37
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
18
Exercise
17
Carboplatin
17
Nivolumab
15
Cisplatin
15
atezolizumab
14
Drug Therapy
13
Paclitaxel
12
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
12
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Glutamyl Aminopeptidase
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled